Literature DB >> 25131793

Sequencing approaches in cancer treatment.

D Sekar1, K Thirugnanasambantham, V I Hairul Islam, S Saravanan.   

Abstract

Use of sequencing approaches is an important aspect in the field of cancer genomics, where next-generation sequencing has already been utilized for targeting oncogenes or tumour-suppressor genes, that can be sequenced in a short time period. Alterations such as point mutations, insertions/deletions, copy number alterations, chromosomal rearrangements and epigenetic changes are encountered in cancer cell genomes, and application of various NGS technologies in cancer research will encounter such modifications. Rapid advancement in technology has led to exponential growth in the field of genomic analysis. The $1000 Genome Project (in which the goal is to sequence an entire human genome for $1000), and deep sequencing techniques (which have greater accuracy and provide a more complete analysis of the genome), are examples of rapid advancements in the field of cancer genomics. In this mini review, we explore sequencing techniques, correlating their importance in cancer therapy and treatment.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25131793      PMCID: PMC6496166          DOI: 10.1111/cpr.12124

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  28 in total

Review 1.  Exome sequencing: a transformative technology.

Authors:  Andrew B Singleton
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  Next-generation sequencing for cancer diagnostics: a practical perspective.

Authors:  Cliff Meldrum; Maria A Doyle; Richard W Tothill
Journal:  Clin Biochem Rev       Date:  2011-11

3.  Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.

Authors:  Dereje D Jima; Jenny Zhang; Cassandra Jacobs; Kristy L Richards; Cherie H Dunphy; William W L Choi; Wing Yan Au; Gopesh Srivastava; Magdalena B Czader; David A Rizzieri; Anand S Lagoo; Patricia L Lugar; Karen P Mann; Christopher R Flowers; Leon Bernal-Mizrachi; Kikkeri N Naresh; Andrew M Evens; Leo I Gordon; Micah Luftig; Daphne R Friedman; J Brice Weinberg; Michael A Thompson; Javed I Gill; Qingquan Liu; Tam How; Vladimir Grubor; Yuan Gao; Amee Patel; Han Wu; Jun Zhu; Gerard C Blobe; Peter E Lipsky; Amy Chadburn; Sandeep S Dave
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

Review 4.  Exome sequencing: dual role as a discovery and diagnostic tool.

Authors:  Chee-Seng Ku; David N Cooper; Constantin Polychronakos; Nasheen Naidoo; Mengchu Wu; Richie Soong
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

Review 5.  Next-generation DNA sequencing methods.

Authors:  Elaine R Mardis
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

6.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

7.  Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.

Authors:  Yakov A Lomakin; Maria Yu Zakharova; Alexey V Stepanov; Maria A Dronina; Ivan V Smirnov; Tatyana V Bobik; Andrey Yu Pyrkov; Nina V Tikunova; Svetlana N Sharanova; Vitali M Boitsov; Sergey Yu Vyazmin; Marsel R Kabilov; Alexey E Tupikin; Alexey N Krasnov; Nadezda A Bykova; Yulia A Medvedeva; Marina V Fridman; Alexander V Favorov; Natalia A Ponomarenko; Michael V Dubina; Alexey N Boyko; Valentin V Vlassov; Alexey A Belogurov; Alexander G Gabibov
Journal:  Mol Immunol       Date:  2014-02-16       Impact factor: 4.407

Review 8.  Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era.

Authors:  Jiajia Chen; Daqing Zhang; Wenying Yan; Dongrong Yang; Bairong Shen
Journal:  Biomed Res Int       Date:  2013-07-15       Impact factor: 3.411

9.  Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.

Authors:  Stephen Q Wong; Jason Li; Renato Salemi; Karen E Sheppard; Hongdo Do; Richard W Tothill; Grant A McArthur; Alexander Dobrovic
Journal:  Sci Rep       Date:  2013-12-13       Impact factor: 4.379

10.  Detection and quantification of methylation in DNA using solid-state nanopores.

Authors:  Jiwook Shim; Gwendolyn I Humphreys; Bala Murali Venkatesan; Jan Marie Munz; Xueqing Zou; Chaitanya Sathe; Klaus Schulten; Farhad Kosari; Ann M Nardulli; George Vasmatzis; Rashid Bashir
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  3 in total

Review 1.  Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".

Authors:  Mohammad Muzafar Beigh
Journal:  Medicines (Basel)       Date:  2016-06-02

2.  LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.

Authors:  Xiaoguang Zhou; Bowen Zeng; Yansheng Li; Haozhou Wang; Xiaodong Zhang
Journal:  Molecules       Date:  2021-11-22       Impact factor: 4.411

Review 3.  CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer.

Authors:  Sushmaa Chandralekha Selvakumar; K Auxzilia Preethi; Kehinde Ross; Deusdedit Tusubira; Mohd Wajid Ali Khan; Panagal Mani; Tentu Nageswara Rao; Durairaj Sekar
Journal:  Mol Cancer       Date:  2022-03-24       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.